The World Anti-Doping Agency (WADA) is pleased to publish its 2025-2029 Strategic Plan, which lays the foundation for WADA’s ...

The World Anti-Doping Agency (WADA) is pleased to publish Professional Standards and Role Descriptors for practitioners ...

The World Anti-Doping Agency (WADA) is pleased to issue a Request for Proposals (RFP) to host regional symposiums in 2026.

As an athlete, you may have an illness or medical condition that requires a particular medication. If this medication contains a substance or requires an administration method that is on the List of ...

Our 16-member Executive Committee is delegated by WADA’s Foundation Board (Board) to manage the running of the Agency, including the performance of activities and the administration of assets. This ...

The World Anti-Doping Agency (WADA) invites stakeholders to participate in a consultation process to revise the following Technical Document (TD) and Technical Letter (TL):  TD2025DBS - Dried Blood ...

The World Anti-Doping Agency (WADA) wishes to remind interested candidates that the deadline to apply for one Independent Member seat of the Agency’s Independent Ethics Board (IEB) is Friday 7 ...

The World Anti-Doping Agency (WADA) confirms that following a thorough review, it will not lodge an appeal to the Court of Arbitration for Sport (CAS) in the case of Polish tennis player, Iga Świątek, ...

This week, the World Anti-Doping Agency (WADA) President, Witold Bańka, was in George Town, Cayman Islands, for the fourth annual WADA Forum with Ministers Responsible for Sport in the Caribbean. The ...

The WADA 19-Norandrosterone (19NA) Working Group (19NA WG) is a specific Working Group created by the WADA Science & Medicine Department at the request of the WADA Laboratory Expert Advisory Group ...